JNK/NN
(/(
c-Jun/NN
NH2-terminal/JJ
kinase/NN
)/)
is/VBZ
a/DT
target/NN
for/IN
antioxidants/NNS
in/IN
T/NN
lymphocytes/NNS
./.

AP-1/NN
has/VBZ
been/VBN
shown/VBN
to/TO
behave/VB
as/IN
a/DT
redox-sensitive/JJ
transcription/NN
factor/NN
that/WDT
can/MD
be/VB
activated/VBN
by/IN
both/CC
oxidant/JJ
and/CC
antioxidant/JJ
stimuli/NNS
./.
=====
However/RB
,/,
the/DT
mechanisms/NNS
involved/VBN
in/IN
the/DT
activation/NN
of/IN
AP-1/NN
by/IN
antioxidants/NNS
are/VBP
largely/RB
unknown/JJ
./.
=====
In/IN
this/DT
study/NN
we/PRP
show/VBP
that/IN
the/DT
structurally/RB
unrelated/JJ
antioxidant/JJ
agents/NNS
pyrrolidine/NN
dithiocarbamate/NN
(/(
PDTC/NN
)/)
,/,
butylated/VBN
hydroxyanisole/NN
,/,
and/CC
Nacetylcysteine/NN
activated/VBD
JNK/NN
(/(
c-Jun/NN
NH2-terminal/JJ
kinase/NN
)/)
in/IN
Jurkat/NN
T/NN
cells/NNS
./.
=====
This/DT
activation/NN
differed/VBD
substantially/RB
from/IN
that/DT
mediated/VBN
by/IN
phorbol/NN
12-myristate/NN
13-acetate/NN
(/(
PMA/NN
)/)
and/CC
Ca2+/NN
ionophore/NN
or/CC
produced/VBN
by/IN
costimulation/NN
with/IN
antibodies/NNS
against/IN
the/DT
T/NN
cell/NN
receptor-CD3/NN
complex/NN
and/CC
to/TO
CD28/NN
./.
=====
The/DT
activation/NN
of/IN
JNK/NN
by/IN
classical/JJ
T/NN
cell/NN
stimuli/NNS
was/VBD
transient/JJ
,/,
whereas/IN
that/DT
mediated/VBN
by/IN
PDTC/NN
and/CC
butylated/VBN
hydroxyanisole/NN
(/(
but/CC
not/RB
N-acetylcysteine/NN
)/)
was/VBD
sustained/JJ
./.
=====
The/DT
kinetics/NNS
of/IN
JNK/NN
activation/NN
correlated/VBD
with/IN
the/DT
expression/NN
of/IN
c-jun/NN
which/WDT
was/VBD
transient/JJ
after/IN
stimulation/NN
with/IN
PMA/NN
plus/CC
ionophore/NN
and/CC
prolonged/VBD
in/IN
response/NN
to/TO
PDTC/NN
,/,
which/WDT
also/RB
transiently/RB
induced/VBD
c-fos/NN
./.
=====
In/IN
addition/NN
,/,
JNK/NN
activation/NN
by/IN
PMA/NN
plus/CC
ionophore/NN
was/VBD
sensitive/JJ
to/TO
inhibitors/NNS
of/IN
signaling/NN
pathways/NNS
involving/VBG
Ca2+/NN
,/,
protein/NN
kinase/NN
C/NN
,/,
and/CC
tyrosine/NN
phosphorylation/NN
,/,
which/WDT
failed/VBD
to/TO
inhibit/VB
the/DT
activation/NN
mediated/VBN
by/IN
PDTC/NN
./.
=====
Transfection/NN
of/IN
trans-dominant/JJ
negative/JJ
expression/NN
vectors/NNS
of/IN
ras/NN
and/CC
raf/NN
,/,
together/RB
with/IN
AP-1-dependent/JJ
reporter/NN
constructs/NNS
,/,
as/RB
well/RB
as/IN
Western/NN
blot/NN
analysis/NN
using/VBG
anti-ERK/JJ
(/(
extracellular/JJ
signal-regulated/JJ
kinase/NN
)/)
antibodies/NNS
,/,
indicated/VBD
that/IN
the/DT
Ras/Raf/ERK/NN
pathway/NN
did/VBD
not/RB
appear/VB
to/TO
mediate/VB
the/DT
effect/NN
of/IN
the/DT
antioxidant/NN
./.
=====
However/RB
,/,
the/DT
combined/JJ
treatment/NN
with/IN
PDTC/NN
and/CC
PMA/NN
,/,
two/CD
agents/NNS
that/WDT
synergize/VBP
on/IN
AP-1/NN
activation/NN
,/,
resulted/VBD
in/IN
the/DT
persistent/JJ
phosphorylation/NN
of/IN
ERK-2/NN
./.
=====
In/IN
conclusion/NN
,/,
our/PRP$
results/NNS
identify/VBP
JNK/NN
as/IN
a/DT
target/NN
of/IN
antioxidant/JJ
agents/NNS
which/WDT
can/MD
be/VB
regulated/VBN
differentially/RB
under/IN
oxidant/JJ
and/CC
antioxidant/JJ
conditions/NNS
./.